Downregulation of CXCR4 also resulted in a robust reduction of the circulating ovarian cancer cells, suggesting a possible role of the SDF1/CXCR4 axis in the hematogenous route of dissemination [25]. The gene discussed is CXCR4; the disease is ovarian cancer.